Radiation Oncology Department, Mater Hospital, Crows Nest, NSW, Australia.
Radiat Oncol. 2011 Sep 5;6:108. doi: 10.1186/1748-717X-6-108.
Radiotherapy technology is expanding rapidly. Volumetric Modulated Arc Therapy (VMAT) technologies such as RapidArc® (RA) may be a more efficient way of delivering intensity-modulated radiotherapy-like (IM) treatments. This study is an audit of the RA experience in an Australian department with a planning and economic comparison to IM.
30 consecutive prostate cancer patients treated radically with RA were analyzed. Eight RA patients treated definitively were then completely re-planned with 3D conformal radiotherapy (3D); and a conventional sliding window IM technique; and a new RA plan. The acceptable plans and their treatment times were compared and analyzed for any significant difference. Differences in staff costs of treatment were computed and analyzed.
Thirty patients had been treated to date with eight being treated definitely to at least 74 Gy, nine post high dose brachytherapy (HDR) to 50.4Gy and 13 post prostatectomy to at least 64Gy. All radiotherapy courses were completed with no breaks. Acute rectal toxicity by the RTOG criteria was acceptable with 22 having no toxicity, seven with grade 1 and one had grade 2.Of the eight re-planned patients, none of the 3D (three-dimensional conformal radiotherapy) plans were acceptable based on local guidelines for dose to organs at risk. There was no statistically significant difference in planning times between IM and RA (p = 0.792). IM had significantly greater MUs per fraction (1813.9 vs 590.2 p < 0.001), total beam time per course (5.2 vs 3.1 hours, p = 0.001) and average treatment staff cost per patient radiotherapy course ($AUD489.91 vs $AUD315.66, p = 0.001). The mean saving in treatment staff cost for RA treatment was $AUD174.25 per patient.
3D was incapable of covering a modern radiotherapy volume for the radical treatment of prostate cancer. These volumes can be treated via conventional IM and RA. RA was significantly more efficient, safe and cost effective than IM. VMAT technologies are a superior way of delivering IM-like treatments.
放射治疗技术正在迅速发展。容积旋转调强弧形治疗(VMAT)技术,如 RapidArc®(RA),可能是提供强度调制放疗(IM)治疗的更有效方法。本研究是对澳大利亚一个部门的 RA 经验进行的审计,对其与 IM 的规划和经济进行了比较。
分析了 30 例接受根治性 RA 治疗的前列腺癌连续患者。然后,对 8 例接受确定性治疗的 RA 患者完全重新进行了 3D 适形放疗(3D)、传统滑动窗口 IM 技术和新的 RA 计划。比较并分析了可接受的计划及其治疗时间,以确定是否存在显著差异。计算并分析了治疗人员成本的差异。
迄今为止,已对 30 例患者进行了治疗,其中 8 例接受了至少 74Gy 的确定性治疗,9 例接受了高剂量近距离放疗(HDR)后 50.4Gy 的治疗,13 例接受了前列腺切除术治疗后至少 64Gy 的治疗。所有放射治疗疗程均顺利完成,无中断。根据 RTOG 标准,急性直肠毒性可接受,22 例无毒性,7 例 1 级,1 例 2 级。在重新规划的 8 例患者中,没有 3D(三维适形放疗)计划根据当地风险器官剂量指南是可接受的。IM 和 RA 之间的计划时间没有统计学上的显著差异(p = 0.792)。IM 每部分的 MU 明显更高(1813.9 对 590.2,p < 0.001),每疗程的总束时间(5.2 对 3.1 小时,p = 0.001)和每位患者的平均放射治疗人员成本(澳元 489.91 对澳元 315.66,p = 0.001)。RA 治疗的平均治疗人员成本节省为每位患者澳元 174.25 澳元。
3D 无法覆盖前列腺癌根治性治疗的现代放射治疗体积。这些体积可以通过常规 IM 和 RA 进行治疗。RA 比 IM 更有效、更安全、更具成本效益。VMAT 技术是提供类似 IM 治疗的优越方法。